Clinical trials
Phase 2 Fibrosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
97 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 6 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 5 |
| 2025 | 10 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
| Recruiting | 17 |
| Terminated | 14 |
| Active, not recruiting | 5 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 14 |
| Gilead Sciences | 10 |
| Conatus Pharmaceuticals Inc. | 3 |
| Genfit | 3 |
| Celgene | 2 |
| Hunter Holmes Mcguire Veteran Affairs Medical Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| Madrigal Pharmaceuticals, Inc. | 2 |
| National Cancer Institute (NCI) | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 97 |
| Non-alcoholic Fatty Liver Disease | 17 |
| Liver Diseases | 13 |
| Liver Cirrhosis | 11 |
| Hepatitis C | 9 |
| Idiopathic Pulmonary Fibrosis | 9 |
| Fatty Liver | 8 |
| Hepatic Encephalopathy | 8 |
| Lung Diseases | 8 |
| Lung Diseases, Interstitial | 8 |
Trials
Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.